Bladder Cancer | Topics

Cancer-Driving Mutations Common in Healthy Bladder Tissue According to Study
October 27, 2020

A recent study published in Science evaluated DNA changes in healthy and disease-laden bladder tissue, finding that cancer-driving mutations are common in healthy bladder tissue.

Tremelimumab, Durvalumab Combo Shows Promise for Certain Patients with Localized Bladder Cancer
October 25, 2020

Combination treatment with tremelimumab and durvalumab was found to be well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who are not eligible for cisplatin-based chemotherapy.

Phase 2 Trial Sees Positive Topline Results with Enfortumab Vedotin-ejfv in Advanced Urothelial Cancer
October 12, 2020

“This is the first trial to report objective responses in patients with advanced urothelial cancer who had previously received immunotherapy but were ineligible for cisplatin in this setting due to inadequate kidney function or other conditions,” Roger Dansey, MD, said in a press release.